Search

Adolf D. Berhane

Examiner (ID: 2145, Phone: (571)272-2077 , Office: P/2838 )

Most Active Art Unit
2838
Art Unit(s)
2102, 2111, 2722, 2838, 2899
Total Applications
4100
Issued Applications
3647
Pending Applications
180
Abandoned Applications
306

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 8270402 [patent_doc_number] => 08211905 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2012-07-03 [patent_title] => 'Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping properties' [patent_app_type] => utility [patent_app_number] => 12/423641 [patent_app_country] => US [patent_app_date] => 2009-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 105 [patent_figures_cnt] => 105 [patent_no_of_words] => 28068 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12423641 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/423641
Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping properties Apr 13, 2009 Issued
Array ( [id] => 5474470 [patent_doc_number] => 20090247636 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'AGENT FOR SUPPRESSION OF GASTRIC EMPTYING COMPRISING 4-HYDROXYISOLEUCINE' [patent_app_type] => utility [patent_app_number] => 12/422488 [patent_app_country] => US [patent_app_date] => 2009-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3699 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20090247636.pdf [firstpage_image] =>[orig_patent_app_number] => 12422488 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/422488
AGENT FOR SUPPRESSION OF GASTRIC EMPTYING COMPRISING 4-HYDROXYISOLEUCINE Apr 12, 2009 Abandoned
Array ( [id] => 5558865 [patent_doc_number] => 20090270442 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'POLYMORPHS OF HYDROCHLORIDE SALT OF 5-(3-(ETHYLSULFONYL)PHENYL)-3,8-DIMETHYL-N-(1-METHYLPIPERIDIN-4-YL)-9H-PYRIDO[2,3-B]INDOLE-7-CARBOXAMIDE AND METHODS OF USE THEREFOR' [patent_app_type] => utility [patent_app_number] => 12/422877 [patent_app_country] => US [patent_app_date] => 2009-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 60 [patent_figures_cnt] => 60 [patent_no_of_words] => 33641 [patent_no_of_claims] => 102 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20090270442.pdf [firstpage_image] =>[orig_patent_app_number] => 12422877 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/422877
POLYMORPHS OF HYDROCHLORIDE SALT OF 5-(3-(ETHYLSULFONYL)PHENYL)-3,8-DIMETHYL-N-(1-METHYLPIPERIDIN-4-YL)-9H-PYRIDO[2,3-B]INDOLE-7-CARBOXAMIDE AND METHODS OF USE THEREFOR Apr 12, 2009 Abandoned
Array ( [id] => 5570358 [patent_doc_number] => 20090253736 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'AZAINDOLE DERIVATIVES AS CFTR MODULATORS' [patent_app_type] => utility [patent_app_number] => 12/422496 [patent_app_country] => US [patent_app_date] => 2009-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25069 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20090253736.pdf [firstpage_image] =>[orig_patent_app_number] => 12422496 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/422496
Azaindole derivatives as CFTR modulators Apr 12, 2009 Issued
Array ( [id] => 6517853 [patent_doc_number] => 20100261731 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'Method for Treating a Disease, Disorder or Adverse Effect Caused by an Elevated Serum Concentration of an UGT1A1 Substrate' [patent_app_type] => utility [patent_app_number] => 12/422434 [patent_app_country] => US [patent_app_date] => 2009-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6552 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20100261731.pdf [firstpage_image] =>[orig_patent_app_number] => 12422434 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/422434
Method for Treating a Disease, Disorder or Adverse Effect Caused by an Elevated Serum Concentration of an UGT1A1 Substrate Apr 12, 2009 Abandoned
Array ( [id] => 6516965 [patent_doc_number] => 20100261684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'Pharmaceutical combination of medication to be used by patients presenting with an acute coronary syndrome so as to stop the process and prevent a myocardial infarction' [patent_app_type] => utility [patent_app_number] => 12/386008 [patent_app_country] => US [patent_app_date] => 2009-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1795 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20100261684.pdf [firstpage_image] =>[orig_patent_app_number] => 12386008 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/386008
Pharmaceutical combination of medication to be used by patients presenting with an acute coronary syndrome so as to stop the process and prevent a myocardial infarction Apr 12, 2009 Abandoned
Array ( [id] => 6516975 [patent_doc_number] => 20100261686 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'Pharmaceutical combination for the treatment of pain (acute or chronic), as powerful as a narcotic medication but non narcotic ,therefore very unlikely to create addiction' [patent_app_type] => utility [patent_app_number] => 12/384881 [patent_app_country] => US [patent_app_date] => 2009-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1120 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20100261686.pdf [firstpage_image] =>[orig_patent_app_number] => 12384881 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/384881
Pharmaceutical combination for the treatment of pain (acute or chronic), as powerful as a narcotic medication but non narcotic ,therefore very unlikely to create addiction Apr 9, 2009 Abandoned
Array ( [id] => 5485781 [patent_doc_number] => 20090275546 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'Diagnostic tests and personalized treatment regimes for cancer stem cells' [patent_app_type] => utility [patent_app_number] => 12/386002 [patent_app_country] => US [patent_app_date] => 2009-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15163 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20090275546.pdf [firstpage_image] =>[orig_patent_app_number] => 12386002 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/386002
Diagnostic tests and personalized treatment regimes for cancer stem cells Apr 9, 2009 Abandoned
Array ( [id] => 5374754 [patent_doc_number] => 20090312315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'PAI-1 INHIBITOR' [patent_app_type] => utility [patent_app_number] => 12/422099 [patent_app_country] => US [patent_app_date] => 2009-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 232953 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20090312315.pdf [firstpage_image] =>[orig_patent_app_number] => 12422099 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/422099
PAI-1 inhibitor Apr 9, 2009 Issued
Array ( [id] => 5485793 [patent_doc_number] => 20090275558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'SUBSTITUTED SULFONAMIDE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/421230 [patent_app_country] => US [patent_app_date] => 2009-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55147 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20090275558.pdf [firstpage_image] =>[orig_patent_app_number] => 12421230 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/421230
Substituted sulfonamide compounds Apr 8, 2009 Issued
Array ( [id] => 9216372 [patent_doc_number] => 08629172 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-14 [patent_title] => 'Methods and compositions for treating post-operative pain comprising clonidine' [patent_app_type] => utility [patent_app_number] => 12/421144 [patent_app_country] => US [patent_app_date] => 2009-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 20 [patent_no_of_words] => 21509 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 188 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12421144 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/421144
Methods and compositions for treating post-operative pain comprising clonidine Apr 8, 2009 Issued
Array ( [id] => 6547960 [patent_doc_number] => 20100016445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'TRANSDERMAL DIETHYLSTILBESTROL FOR TREATING PROSTATE CANCER' [patent_app_type] => utility [patent_app_number] => 12/421471 [patent_app_country] => US [patent_app_date] => 2009-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11882 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016445.pdf [firstpage_image] =>[orig_patent_app_number] => 12421471 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/421471
TRANSDERMAL DIETHYLSTILBESTROL FOR TREATING PROSTATE CANCER Apr 8, 2009 Abandoned
Array ( [id] => 5570420 [patent_doc_number] => 20090253798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'COLCHICINE SOLID COMPLEX; METHODS OF MAKING; AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/416990 [patent_app_country] => US [patent_app_date] => 2009-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6207 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20090253798.pdf [firstpage_image] =>[orig_patent_app_number] => 12416990 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/416990
Colchicine solid complex; methods of making; and methods of use thereof Apr 1, 2009 Issued
Array ( [id] => 5474387 [patent_doc_number] => 20090247553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'Highly Pure Paliperidone or a Pharmaceutically Acceptable Salt Thereof Substantially Free of Keto Impurity' [patent_app_type] => utility [patent_app_number] => 12/411526 [patent_app_country] => US [patent_app_date] => 2009-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9933 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20090247553.pdf [firstpage_image] =>[orig_patent_app_number] => 12411526 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/411526
Highly Pure Paliperidone or a Pharmaceutically Acceptable Salt Thereof Substantially Free of Keto Impurity Mar 25, 2009 Abandoned
Array ( [id] => 5474409 [patent_doc_number] => 20090247575 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'STABILIZING LIPID COMPOSITIONS FOR ORAL PHARMACEUTICAL AGENTS' [patent_app_type] => utility [patent_app_number] => 12/412029 [patent_app_country] => US [patent_app_date] => 2009-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16353 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20090247575.pdf [firstpage_image] =>[orig_patent_app_number] => 12412029 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/412029
STABILIZING LIPID COMPOSITIONS FOR ORAL PHARMACEUTICAL AGENTS Mar 25, 2009 Abandoned
Array ( [id] => 9551604 [patent_doc_number] => 08758648 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-24 [patent_title] => 'Stabilizer of color former and use thereof' [patent_app_type] => utility [patent_app_number] => 12/933569 [patent_app_country] => US [patent_app_date] => 2009-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11381 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12933569 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/933569
Stabilizer of color former and use thereof Mar 17, 2009 Issued
Array ( [id] => 9844380 [patent_doc_number] => 08946297 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-03 [patent_title] => 'Solid composition for pest control' [patent_app_type] => utility [patent_app_number] => 12/919428 [patent_app_country] => US [patent_app_date] => 2009-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 3946 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12919428 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/919428
Solid composition for pest control Mar 17, 2009 Issued
Array ( [id] => 6136989 [patent_doc_number] => 20110009453 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => ' S1P3 RECEPTOR INHIBITORS FOR TREATING INFLAMMATION' [patent_app_type] => utility [patent_app_number] => 12/922629 [patent_app_country] => US [patent_app_date] => 2009-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7205 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20110009453.pdf [firstpage_image] =>[orig_patent_app_number] => 12922629 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/922629
S1P3 RECEPTOR INHIBITORS FOR TREATING INFLAMMATION Mar 15, 2009 Abandoned
Array ( [id] => 9761886 [patent_doc_number] => 08846205 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-30 [patent_title] => 'Hybrid strategies for reducing leaching of metal biocides from biodegradable substrates' [patent_app_type] => utility [patent_app_number] => 12/381460 [patent_app_country] => US [patent_app_date] => 2009-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15240 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 186 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12381460 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/381460
Hybrid strategies for reducing leaching of metal biocides from biodegradable substrates Mar 11, 2009 Issued
Array ( [id] => 7687491 [patent_doc_number] => 20090176800 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'IN VIVO SCREENING METHOD OF THERAPEUTIC AGENT FOR MEMORY/LEARNING DYSFUNCTIONS BY SCHIZOPHRENIA' [patent_app_type] => utility [patent_app_number] => 12/401958 [patent_app_country] => US [patent_app_date] => 2009-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5983 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20090176800.pdf [firstpage_image] =>[orig_patent_app_number] => 12401958 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/401958
Method of treating memory/learning dysfunctions caused by schizophrenia with lurasidone Mar 10, 2009 Issued
Menu